The disease has been estimated to cost the UK trout industry approximately £2.5 million per year and is one of the main research topics in the Aquatic Vaccine Unit at Stirling. Both short and longterm approaches are being taken to tackle this disease, including the testing of novel treatments, elucidation of the life cycle, development of a vaccine to prevent PKD, and selective breeding of PKDtolerant fish.

Address: 5M Enterprises Ltd., 4 Haywood House, Hydra Business Park, Nether Lane, Sheffield, S35 9ZX, England.
Website: http://www.thefishsite.com/articles/420/current-research-on-pkd-at-stirling